Gabapentin has one well-documented lab test interference: it can cause false positive results on certain urine protein dipstick tests. Beyond that, it can influence blood glucose readings, rarely affect blood cell counts, and complicate some drug screening methods. If you’re taking gabapentin and have upcoming lab work, here’s what to know about each test it may affect.
False Positive Urine Protein Tests
The most clearly established lab interference is with urine protein testing. The FDA label for gabapentin specifically warns that false positive readings have been reported when using the Ames N-Multistix SG dipstick test for urinary protein. This means a routine urinalysis could incorrectly suggest you have protein in your urine, which normally prompts concern about kidney problems.
The fix is straightforward. The FDA recommends using a different method called sulfosalicylic acid precipitation, which is not affected by gabapentin. If your dipstick urinalysis comes back positive for protein while you’re on gabapentin, your provider should confirm the result with this more specific test before drawing any conclusions about your kidney health.
Blood Glucose and HbA1c Levels
Gabapentin doesn’t interfere with how glucose tests work in the lab, but it may change the numbers themselves. About 1.2% of people taking gabapentin experience elevated blood sugar, compared to 0.4% on placebo. Hypoglycemia (low blood sugar) has also been reported, though less frequently.
For people with diabetes, this matters in a practical way. In one documented case, a 63-year-old man with well-controlled type 2 diabetes saw his fasting glucose climb to the 150 to 165 mg/dL range within two weeks of starting gabapentin, after months of readings in the target range. His HbA1c also trended upward over the following months. While a single case report doesn’t prove causation, a randomized trial in diabetic neuropathy patients found no significant changes in HbA1c, possibly because the study was too short to detect them.
If you have diabetes and notice unexplained glucose fluctuations after starting or increasing gabapentin, the medication is worth considering as a contributing factor. This isn’t a lab interference issue but rather a real physiological effect that shows up on lab work.
Drug Screening Complications
Gabapentin can cause problems with urine drug screens, particularly for amphetamines. In laboratory analysis, high concentrations of gabapentin in urine can overload the separation columns used in confirmatory testing, creating interference that mimics an amphetamine signal. One study found this occurred in roughly 4% of patient samples when a simpler sample preparation method was used. The issue was resolved with more thorough extraction techniques, but not every lab uses those methods.
If you test positive for amphetamines on a drug screen while taking gabapentin, request confirmatory testing and make sure the lab is aware of your gabapentin use. Labs that use solid-phase extraction and adjusted separation techniques can distinguish gabapentin from amphetamines reliably.
Liver Enzyme Panels
Gabapentin is generally considered safe for the liver. In clinical trials for both epilepsy and diabetic neuropathy, gabapentin was not associated with increased rates of liver enzyme elevations compared to placebo. A systematic review found that while 4% of children on phenytoin and 6% on valproate showed elevated liver enzymes, none were reported on gabapentin.
Liver injury from gabapentin does exist but is extremely rare. Among 899 cases of drug-induced liver injury tracked in a major U.S. study over nearly a decade, only 3 were attributed to gabapentin. Those cases appeared 3 to 6 weeks after starting the drug, showed a pattern of bile flow disruption rather than direct liver cell damage, and resolved on their own after the medication was stopped. Given that millions of people take gabapentin, this rate is vanishingly low. Routine liver enzyme monitoring is not recommended.
White Blood Cell Counts
Gabapentin has been linked to neutropenia, a drop in a specific type of white blood cell that helps fight infection. This is considered a rare adverse effect. Case reports document it occurring in patients taking gabapentin for neuropathic pain, but large-scale data on how often it happens are limited. If your complete blood count shows low neutrophils while you’re on gabapentin and there’s no other obvious explanation, the medication could be a factor worth discussing with your provider.
Kidney Function and Drug Level Timing
Gabapentin doesn’t interfere with kidney function tests, but your kidney function directly determines how your body handles gabapentin. The drug is eliminated almost entirely through the kidneys, and its half-life stretches from a normal 5 to 7 hours all the way to 52 hours when kidney filtration drops below 30 mL/min. Doses are adjusted at specific thresholds: reduced frequency when filtration is between 30 and 59 mL/min, once daily when it falls between 15 and 29 mL/min, and a much smaller dose below 15 mL/min. People on hemodialysis typically receive a supplemental dose after each session.
If you’re having your gabapentin blood level tested, Quest Diagnostics recommends drawing the sample 2 hours after your last dose. This timing captures the peak concentration and gives the most useful reading. The FDA notes that routine monitoring of gabapentin blood levels hasn’t been shown to be necessary for safe use, but levels may be checked if toxicity or non-response is a concern, especially in people with reduced kidney function where the drug can accumulate.
What to Tell Your Provider Before Lab Work
The most important step is making sure every provider ordering your labs knows you take gabapentin. This is especially relevant if you’re getting a urinalysis, a urine drug screen, or glucose monitoring. For urinalysis, the dipstick protein result should be confirmed with a more specific method. For drug screens, the lab can adjust its technique to avoid misidentifying gabapentin as amphetamine. For glucose, your provider can factor in the small possibility that gabapentin is contributing to any unexpected shifts.
Routine blood monitoring is not required while taking gabapentin. The FDA prescribing information states that clinical trial data do not indicate a need for regular lab surveillance. The exceptions are kidney function checks if you have renal disease (since dosing depends on it) and targeted testing if you develop symptoms like unusual bruising, signs of infection, or yellowing of the skin.